TY - JOUR
T1 - Management of severe pyogenic spinal infections
T2 - the 2SICK study by the EANS spine section
AU - Kramer, Andreas
AU - Thavarajasingam, Santhosh G.
AU - Neuhoff, Jonathan
AU - Lange, Felipa
AU - Ponniah, Hariharan Subbiah
AU - Lener, Sara
AU - Thomé, Claudius
AU - Stengel, Felix C.
AU - Fischer, Gregor
AU - Hostettler, Isabel C.
AU - Stienen, Martin N.
AU - Jemna, Maxim
AU - Gousias, Konstantinos
AU - Nedeljkovic, Aleksandra
AU - Grujicic, Danica
AU - Nedeljkovic, Zarko
AU - Poluga, Jasmina
AU - Schär, Ralph T.
AU - Urbanski, Wiktor
AU - Sousa, Carla
AU - Casimiro, Carlos Daniel Oliveira
AU - Harmer, Helena
AU - Ladisich, Barbara
AU - Matt, Matthias
AU - Simon, Matthias
AU - Pai, Delin
AU - Doenitz, Christian
AU - Mongardi, Lorenzo
AU - Lofrese, Giorgio
AU - Buchta, Melanie
AU - Grassner, Lukas
AU - Trávníček, Pavel
AU - Hosszú, Tomáš
AU - Wissels, Maarten
AU - Bamps, Sven
AU - Hamouda, Waeel
AU - Panico, Flavio
AU - Garbossa, Diego
AU - Barbato, Marcello
AU - Barbarisi, Manlio
AU - Pantel, Tobias
AU - Gempt, Jens
AU - Kasula, Tharaka Sai
AU - Desai, Sohum
AU - Vitowanu, Julius Mautin
AU - Rovčanin, Bekir
AU - Omerhodzic, Ibrahim
AU - Demetriades, Andreas K.
AU - Davies, Benjamin
AU - Shiban, Ehab
AU - Ringel, Florian
N1 - Publisher Copyright:
© 2024 The Author(s)
PY - 2025
Y1 - 2025
N2 - BACKGROUND CONTEXT: Spondylodiscitis management presents significant clinical challenges, particularly in critically ill patients, where the risks and benefits of surgical intervention must be carefully balanced. The optimal timing of surgery in this context remains a subject of debate. PURPOSE: This study aims to evaluate the effectiveness of early surgery versus delayed surgery or conservative management in critically ill patients with de novo pyogenic spondylodiscitis. STUDY DESIGN/SETTING: This is an international, multicenter retrospective cohort study involving 24 centers, primarily in Europe. PATIENT SAMPLE: The study included 192 critically ill patients (65.63% male) with a median age of 69 years, all severely affected by pyogenic spondylodiscitis characterized by an initial CRP level >200 mg/l or the presence of two out of four Systemic Inflammatory Response Syndrome criteria upon admission. OUTCOME MEASURES: The primary outcome was 30-day mortality. Secondary outcomes included length of ICU stay, length of hospital stay, and relapse rates of spondylodiscitis. METHODS: Patients were divided into three groups: early surgery (within three days of admission), delayed surgery (after three days of admission), and conservative therapy. Propensity score matching and multivariate regression analyses were performed to adjust for baseline differences and assess the impact of treatment modalities on mortality and other clinical outcomes. RESULTS: Delayed surgery was associated with significantly lower 30-day mortality (4.05%) compared to early surgery (27.85%) and conservative therapy (27.78%) (p<.001). Delayed surgery also resulted in shorter hospital stays (42.76 days) compared to conservative therapy (55.53 days) and early surgery (26.33 days) (p<.001), and shorter ICU stays (4.52 days) compared to conservative therapy (16.48 days) and early surgery (7.92 days) (p<.001). The optimal window for surgery, minimizing mortality, was identified as ten to fourteen days post-admission (p=.02). Risk factors for increased mortality included age (p<.05), multiple organ failure (p<.05), and vertebral body destruction (p<.05), whereas delayed surgery (p<.05) and the presence of an epidural abscess were associated with reduced mortality (p<.05). CONCLUSIONS: Delayed surgery, optimally between 10 to 14 days post-admission, was associated with lower mortality in critically ill spondylodiscitis patients. These findings highlight the potential benefits of considering surgical timing to improve patient outcomes.
AB - BACKGROUND CONTEXT: Spondylodiscitis management presents significant clinical challenges, particularly in critically ill patients, where the risks and benefits of surgical intervention must be carefully balanced. The optimal timing of surgery in this context remains a subject of debate. PURPOSE: This study aims to evaluate the effectiveness of early surgery versus delayed surgery or conservative management in critically ill patients with de novo pyogenic spondylodiscitis. STUDY DESIGN/SETTING: This is an international, multicenter retrospective cohort study involving 24 centers, primarily in Europe. PATIENT SAMPLE: The study included 192 critically ill patients (65.63% male) with a median age of 69 years, all severely affected by pyogenic spondylodiscitis characterized by an initial CRP level >200 mg/l or the presence of two out of four Systemic Inflammatory Response Syndrome criteria upon admission. OUTCOME MEASURES: The primary outcome was 30-day mortality. Secondary outcomes included length of ICU stay, length of hospital stay, and relapse rates of spondylodiscitis. METHODS: Patients were divided into three groups: early surgery (within three days of admission), delayed surgery (after three days of admission), and conservative therapy. Propensity score matching and multivariate regression analyses were performed to adjust for baseline differences and assess the impact of treatment modalities on mortality and other clinical outcomes. RESULTS: Delayed surgery was associated with significantly lower 30-day mortality (4.05%) compared to early surgery (27.85%) and conservative therapy (27.78%) (p<.001). Delayed surgery also resulted in shorter hospital stays (42.76 days) compared to conservative therapy (55.53 days) and early surgery (26.33 days) (p<.001), and shorter ICU stays (4.52 days) compared to conservative therapy (16.48 days) and early surgery (7.92 days) (p<.001). The optimal window for surgery, minimizing mortality, was identified as ten to fourteen days post-admission (p=.02). Risk factors for increased mortality included age (p<.05), multiple organ failure (p<.05), and vertebral body destruction (p<.05), whereas delayed surgery (p<.05) and the presence of an epidural abscess were associated with reduced mortality (p<.05). CONCLUSIONS: Delayed surgery, optimally between 10 to 14 days post-admission, was associated with lower mortality in critically ill spondylodiscitis patients. These findings highlight the potential benefits of considering surgical timing to improve patient outcomes.
KW - Conservative Stabilization
KW - Mortality Rates
KW - Pyogenic Spondylodiscitis
KW - Sepsis
KW - Severe Spinal Infection
KW - Surgical Timing
UR - http://www.scopus.com/inward/record.url?scp=85214265939&partnerID=8YFLogxK
U2 - 10.1016/j.spinee.2024.12.018
DO - 10.1016/j.spinee.2024.12.018
M3 - Article
C2 - 39672206
AN - SCOPUS:85214265939
SN - 1529-9430
JO - Spine Journal
JF - Spine Journal
ER -